Clinical Trial Update: Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating safety and efficacy of glibenclamide combined with rt-PA in acute stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Glibenclamide (glibenclamide)
• rt-PA (tissue plasminogen activator)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Stroke | Phase 2, Phase 3 | Status: COMPLETED